©The Author(s) 2025.
World J Gastroenterol. Nov 7, 2025; 31(41): 110955
Published online Nov 7, 2025. doi: 10.3748/wjg.v31.i41.110955
Published online Nov 7, 2025. doi: 10.3748/wjg.v31.i41.110955
Figure 4 In vitro assessment of the effects of growth differentiation factor 15 on intestinal barrier tight junctions.
A and B: Representative images of an untreated organoid stained with 4’-6-diamidino-2-phenylindole (DAPI) (A) and zonula occludens (ZO)-1 (B); C and D: Representative images of an organoid from the same line, treated with 100 ng/mL of GDF15, stained with DAPI (C) and ZO-1 (D). Scale bar: 100 μm; E: Relative ZO-1 fluorescence values normalized to DAPI. Data are presented as mean ± SD relative to the untreated organoid. Images were obtained using a Leica SP5 confocal microscope with a 20 × objective and analyzed in ImageJ. For each organoid line, ≥ three organoids from three different wells were analyzed. bP < 0.001, one-tailed paired t-test. GDF: Growth differentiation factor; ZO-1: Zonula occludens-1; IFNg: Interferon gamma.
-
Citation: Ruiz-Malagón AJ, Herraiz-Vilela M, Serrano-Pino R, García-Ávila P,
Díaz- Suárez L, Carmona-Segovia AD, Becerra-Munoz VM, Jiménez-Navarro M, Arranz-Salas I, López-Villodres JA, Fernández-Castañer A, Gutiérrez-Martínez F, Rodríguez-González FJ, Camargo-Camero R, Alcaín-Martínez G, Rodríguez-Díaz C, García-Fuentes E, Sánchez-Quintero MJ, López-Gómez C. Growth differentiation factor 15 alters intestinal barrier and increases permeability: A new molecular target in inflammatory bowel disease. World J Gastroenterol 2025; 31(41): 110955 - URL: https://www.wjgnet.com/1007-9327/full/v31/i41/110955.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i41.110955